Skip to main content
. 2018 May 3;59(4):524–538. doi: 10.3349/ymj.2018.59.4.524

Table 6. Complications and Subsequent Surgeries between the Two Surgical Groups.

Outcomes N of studies Minimally invasive group Open group OR (95% CI)
N of OR events (%) Total N of patients N of events (%) Total N of patients
Surgical-site complications
 Overall 7 5 (1.7) 302 13 (4.5) 289 0.4 (0.2 to 1.1)
 Infection 6 3 (1.2) 260 13 (5.3) 246 0.3 (0.1 to 0.9)*
  Surgical-site infection 3 0 (0.0) 159 5 (3.3) 152 0.2 (0.02 to 0.9)
  Superficial wound infection 3 2 (2.0) 101 7 (7.4) 94 0.3 (0.02 to 1.4)
  Deep wound infection 1 1 (3.1) 32 1 (3.4) 29 0.9 (0.05 to 15.1)
 Hematoma 2 2 (2.5) 79 0 (0.0) 73 2.8 (0.3 to 27.6)
Neurological complications
 Overall 7 13 (4.5) 288 13 (4.7) 278 0.8 (0.4 to 1.8)
 Dural tear/CSF leak 7 12 (4.2) 288 11 (4.0) 278 0.9 (0.4 to 2.1)
 Nerve root injury (L5 root paresis) 1 1 (5.6) 18 0 (0.0) 18 3.2 (0.1 to 83.2)
 Postoperative radiculopathy (transient L3 radicular pain) 2 0 (0.0) 55 2 (4.2) 48 0.3 (0.03 to 2.9)
Hardware complications
 Overall 6 14 (5.4) 258 9 (3.6) 250 1.2 (0.5 to 2.6)
 Screw-related complications 6 8 (3.1) 258 2 (0.8) 250 1.8 (0.6 to 5.8)
  Screw malposition 4 4 (2.0) 196 2 (1.0) 194 1.1 (0.3 to 5.1)
  Screw loosening 1 2 (11.1) 18 0 (0.0) 18 5.6 (0.3 to 125.4)
  Screw breakage 1 1 (5.6) 18 0 (0.0) 18 3.2 (0.1 to 83.2)
  Overlong screw 1 1 (2.3) 44 0 (0.0) 38 2.7 (0.1 to 67.1)
 Cage-related complications 3 5 (4.1) 122 7 (5.9) 119 0.7 (0.2 to 2.2)
  Cage migration 2 5 (4.8) 104 6 (5.9) 101 0.8 (0.2 to 2.7)
  Cage fracture during insertion 1 0 (0.0) 18 1 (5.6) 18 0.3 (0.01 to 8.3)
 Graft dislodgement 1 1 (2.4) 42 0 (0.0) 43 3.1 (0.1 to 79.4)
Pseudarthrosis 9 12 (3.3) 363 9 (2.6) 344 1.2 (0.5 to 2.9)
Other complications
 Overall 3 3 (2.4) 127 7 (5.8) 120 0.6 (0.2 to 1.9)
 Deep vein thrombosis 1 0 (0.0) 37 1 (3.3) 30 0.3 (0.01 to 6.7)
 Myocardial infarction 1 0 (0.0) 72 1 (1.4) 72 0.3 (0.01 to 8.2)
 Pneumonia 1 1 (1.4) 72 1 (1.4) 72 1.0 (0.06 to 16.3)
 Paralytic ileus 1 0 (0.0) 37 3 (10) 30 0.1 (0.005 to 2.1)
 Urinary tract infection 1 1 (2.7) 37 0 (0.0) 30 2.5 (0.1 to 63.8)
 Postoperative anemia 1 0 (0.0) 72 1 (1.4) 72 0.3 (0.01 to 8.2)
 Brachial plexus injury due to positioning 1 1 (5.6) 18 0 (0.0) 18 3.2 (0.1 to 83.2)
Subsequent surgeries
 Overall 6 11 (4.4) 251 9 (3.7) 242 0.9 (0.4 to 2.3)
 Revision 4 5 (2.6) 196 2 (1.0) 194 1.1 (0.3 to 4.5)
  Revision for malpositioned screw 4 4 (2.0) 196 2 (1.0) 194
  Revision for migrated cage 1 1 (3.1) 32 0 (0.0) 29
 Removal for pseudarthrosis 3 3 (3.4) 87 3 (3.9) 77 1.3 (0.2 to 7.9)
 Reoperation 4 3 (1.5) 196 4 (2.1) 194 0.6 (0.1 to 2.8)
  Reoperation for graft dislodgement 1 1 (2.4) 42 0 (0.0) 43
  Reoperation for surgical-site infection 2 0 (0.0) 122 3 (2.5) 122
  Reoperation for deep wound infection 1 1 (3.1) 32 1 (3.4) 29
  Reoperation for hematoma 1 1 (2.4) 42 0 (0.0) 43
 Supplemental fixation 0 0 (0.0) 0 0 (0.0) 0

N, number; OR, odds ratio; CI, confidence interval; CSF, cerebrospinal fluid.

*p=0.02, p=0.04, Complications lead to a subsequent surgical intervention. Subsequent surgical intervention was categorized as follows: a revision is a procedure that adjusts or in any way modifies or removes part of the original implant configuration, with or without replacement of a component; a revision may also include adjusting the position of the original configuration (revision for migrated cage, removal of screws, etc.). A removal is a procedure where all of the original system configuration are removed with or without replacement (removal for pain at operative site but after fusion, for pseudarthrosis, etc.). A reoperation is any surgical procedure at the involved level(s) that does not removal, modification, or addition of any components to the system. A supplemental fixation is a procedure in which additional instrumentation not under study in the protocol is implanted.